Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Procedural Characteristics

From: Early hemodynamic performance of the Trifecta™ surgical bioprosthesis aortic valve in Indian patient population: 12 month outcomes of the EVEREST post-market study

  All (n = 100)
Cardiopulmonary bypass time (min) 112.1 ± 49.23 (98)
Aortic cross clamp time (min) 78.35 ± 33.77 (98)
Suture technique, n (%)
 Simple interrupted 51/100 (51%)
 Continuous 3/100 (3%)
 Everting mattress 7/100 (7%)
 Non-everting mattress 22/100 (22%)
 Other 18/100 (18%)
Concomitant surgical procedure, n (%)
 Coronary artery bypass graphing 28/100 (28%)
 Mitral valve repair 2/100 (2%)
 Other 3/100 (3%)
Implanted valve size
 19 mm 36
 21 mm 45
 23 mm 13
 25 mm 5
 27 mm 1
  1. n Total number of patients, min Minutes, mm Millimeter